On Monday AbbVie proclaimed that its newest arthritis medication, Rinvoq, outperformed the company’s established best-selling product Humira in a head-to-head clinical study. These findings represent a substantial achievement for AbbVie as it...
Novo Nordisk has made a significant advance in the rare disease sector by signing a definitive asset purchase and license agreement with Omeros Corporation to acquire its clinical-stage MASP-3 inhibitor zaltenibart...
CDSCO has given approval to Reliance Life Sciences Pvt. Ltd. for conducting a Phase I/III clinical trial of its biosimilar Nivolumab (R-TPR-067, RLS-Nivolumab). The approval is subsequent to the Subject Expert Committee (Oncology).
Roche announced it will present over 30 abstracts on more than 10 different types of cancer at the European Society for Medical Oncology (ESMO) Congress 2025, highlighting its commitment to progressing cancer care.
In a significant public health milestone, the World Health Organization (WHO) has recognized the Maldives for successfully eliminating mother-to-child transmission (EMTCT) of hepatitis B, while also upholding its previous validation (in 2019) for EMT
Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries, announced that the U.S. Food and Drug Administration have approved UZEDY (risperidone). It is an extended-release injection to be administered once-monthly, for...
Thermo Fisher Scientific, has come up with a new lab test which needs to be developed locally, aimed at the better detection of lung transplant rejection and injury. The Molecular Microscope Diagnostic System for Lung
Today, ensuring innovation remains accessible is paramount. We are now able to deliver therapies like CAR-T at 5–8% of the cost compared to the U.S., without compromising on quality or outcomes. Currently, India’s strategic investments in local manuf
Eli Lilly and Company has released new findings showing Omvoh (mirikizumab-mrkz) is the first and only interleukin-23p19 (IL-23p19), used for the treatment of moderately to severely active ulcerative colitis (UC) to report sustained, long-term...
ENTOD Pharmaceuticals announced the release of OCUBIOME, the first ocular probiotic blend in India formulated for healthy eyes. It said its proprietary formulation was developed by its research center in Navi Mumbai. ENTOD Pharmaceuticals...